Fund Holdings — Ally Bridge Group (NY) LLC

Total Portfolio Value:
$63.00M
Total Bought:
$38.38M
Total Sold:
$95.25M
Net Transaction:
-$56.87M
Notable People:
Slanix Paul T Alex
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ABIVAX Société AnonymeADS(ABVX)070,000+70,000$0$9.44M14.98%+$9.44M
Soleno Therapeutics Inc302,483168,029-134,454$20.45M$7.78M12.35%-$12.67M
Atai Beckley NvSHS2,287,0051,713,105-573,900$12.10M$7.01M11.12%-$5.09M
Inventiva S.A.ADS(IVA)01,500,000+1,500,000$0$6.97M11.07%+$6.97M
Minerva Neurosciences, Inc.(NERV)01,655,500+1,655,500$0$6.66M10.56%+$6.66M
Praxis Precision Medicines, Inc.(PRAX)019,882+19,882$0$5.86M9.30%+$5.86M
Edgewise Therapeutics, Inc.(EWTX)0195,000+195,000$0$4.84M7.68%+$4.84M
Eupraxia Pharmaceuticals Inc.(EPRX)915,000397,895-517,105$5.40M$3.00M4.77%-$2.39M
Ovid Therapeutics Inc.(OVID)01,785,000+1,785,000$0$2.91M4.62%+$2.91M
Taysha Gene Therapies, Inc.(TSHA)1,898,112457,132-1,440,980$6.21M$2.51M3.99%-$3.69M
Solid Biosciences Inc549,182413,625-135,557$3.39M$2.33M3.70%-$1.06M
Whitehawk Therapeutics, Inc.(WHWK)817,939817,9390$1.55M$1.98M3.14%+$425.3K
ProMIS Neurosciences, Inc.(PMN)0249,339+249,339$0$1.70M2.70%+$1.70M
Amylyx Pharmaceuticals, Inc.(AMLX)437,3910-437,391$5.94M$0—-$5.94M
Arcutis Biotherapeutics, Inc.(ARQT)233,2200-233,220$4.40M$0—-$4.40M
Ascendis Pharma A/SADR(ASND)51,0800-51,080$10.16M$0—-$10.16M
Avalo Therapeutics, Inc.(AVTX)178,1000-178,100$2.26M$0—-$2.26M
COMPASS Pathways plcADS(CMPS)1,026,3820-1,026,382$5.88M$0—-$5.88M
LENZ Therapeutics, Inc.(LENZ)175,3630-175,363$8.17M$0—-$8.17M
Madrigal Pharmaceuticals, Inc.(MDGL)32,6620-32,662$14.98M$0—-$14.98M
Mind Medicine Mindmed Inc361,4440-361,444$4.26M$0—-$4.26M
Monopar Therapeutics Inc.(MNPR)64,4550-64,455$5.26M$0—-$5.26M
Promis Neurosciences Inc6,233,4970-6,233,497$2.65M$0—-$2.65M
Tarsus Pharmaceuticals, Inc.(TARS)70,7780-70,778$4.21M$0—-$4.21M
Tectonic Therapeutic, Inc.(TECX)138,5950-138,595$2.17M$0—-$2.17M
Page 1 of 1